| Company | Designation | Period |
|---|---|---|
| Becton Dickinson | Business Head- Diagnostics | Sep 1996 – Feb 2001 |
| Avantor Performance Materials, Inc. | EVP & Country Head - India | Mar 2011 – Mar 2015 |
| Ranbaxy | Director-Chemicals | Mar 2001 – Dec 2002 |
| GLAXO LABORATORIES LIMITED | Zonal Sales Manager | Jul 1980 – Jul 1991 |
| Ranbaxy | Director - Allied business | Jan 2003 – Nov 2005 |
| RFCL | CEO & Managing Director | Dec 2005 – Feb 2011 |
| Ranbaxy | All India Sales Manger | Aug 1991 – Aug 1996 |
| NextGen Invitro Diagnostics Pvt Ltd | Co-Founder and Chairman | Jan 2015 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Ngivd corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Sushil Mehta's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Ngivd's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)